Our results revealed for the first time that RNF181 may be a causal gene for CAD, possibly through decreasing the degradation of VEGF2 mediated by the NEDD4 and ERK/MAPK signaling pathways. This evidence concerns the gene NEDD4 and coronary artery disorder.